Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 16Sarcoma 3Lymphoid 3Other hematologic neoplasm 2Thoracic 1Plasma cell 1Genitourinary 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2260Lung Neoplasms 1048Small Cell Lung Carcinoma 402Adenocarcinoma of Lung 154Mesothelioma, Malignant 120Breast Neoplasms 110Neoplasms 106Brain Neoplasms 101Neoplasm Metastasis 95Melanoma 72Mesothelioma 70NSCLC 68Colorectal Neoplasms 68Adenocarcinoma, Bronchiolo-Alveolar 56Thymoma 53Pancreatic Neoplasms 52Ovarian Neoplasms 46Head and Neck Neoplasms 46Carcinoma, Renal Cell 43Carcinoma 38Stomach Neoplasms 36Sarcoma 35Prostatic Neoplasms 35Esophageal Neoplasms 34Adenocarcinoma 34Uterine Cervical Neoplasms 33Squamous Cell Carcinoma of Head and Neck 33Pleural Effusion, Malignant 33Recurrence 27Urinary Bladder Neoplasms 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cardiotoxicity × Thoracic × Clear all
NCT03862131 2025-07-29

PROACT

Washington University School of Medicine

Phase 2 Terminated
49 enrolled 12 charts
BreastLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Sarcoma, Neoplasms, Plasma Cell, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡